ML20137P187

Semiannual Effluent Release Rept for 850107-850630

ML20137P187
Person / Time
Site:	Catawba
Issue date:	06/30/1985
From:	Tucker H DUKE POWER CO.
To:	Grace J NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION II)
References
NUDOCS 8509190547
Download: ML20137P187 (11)

Text

e D

?.

.a

?

CATAu H NUCLEAR STATIOll EFFLUENT ANO WAllE O!5P05AL SWPLEENTE IWORMf!M M PW I M IE:

MIN 195 PERIN COUGEB STMT NT = Del

$10p Hf a tel I. MCULATORT LIMIT 5 l

A. NOOLE CASE 5 - AIR 90$E B. LIRUID EFFLUENT 5 - 905E

1. CALEll8M IUARIES - CAMM 90$E = 5 M40

1. CALENDAR SUMIER - IOTE BOOT DO5E = 1.5 MMM

2. CALENHR OUARTER - BETA 90W = 10 IIRAS

2. CRENHA OUARTER - ORCM DOM

= 5 MREM

1. CRENSAR TEAR

- CAMM 90K = 101940

3. CRENHS TEM

- TOTAL BMT 905E = 3 MREN

4. CALENBM TEM

- MTA 90$E = N ISAS

4. CRENHA TEM

- ORCM DOM

= te IIREN C. IOBINE - 131 ANO 133, TRIf!UN, PARIICULAft1 Uli 112 ) B B415 - ORC M DOSE

1. CALENOM OUARTER = 1.5 MMR

2. CRENDM YEM

= 15 MAEN II. M11Mun PEMI551ktE CONCENTRATIONS A CASEOUS EFFLMNIS - IWORMTION FOUNO l'I OFF5IIE DO5E CALCUL41!Oll MNUAL B. Llquit EFFLENil - IWORMei!IN FOUW IN IOCTR29, APPENIX 8, IASLE !!, COLINEl 2 III. AUDACE EMRCT - MT APPLICABLE It. MA5UREMENT5 ANI APPRet!MTIONS OF 187K RADIO 4CIIrlit IWORMTION FOUNO IN OFF5 tit BOK CRCMATIOll MMUAL v SATCH MLEA5ES A L10U!B EFFLUENT

1. 2.6M102 = TOIR NUMBER OF MICM MLEASE5 2.1.64Et94 = TOTAL. IINElRIN.I FM BAICil MLE45E5.

3 f.55 Eft 2 = MIINist IIKIRIN.I FOR A BATCM MLEASE.

4. 4.14Ef tt = ATERACE IIMIMIN.I FOR A BATCM RELEASE.

5. 3.00EtH = MINIMUR TIMININ.I FOR A BATCH MLE45E.

6. 2.12Et96 = AMRACE IILUTION MTER FLOu BURIIIC MLEASEllCPNI B CASEOUS EFFLUENT

1. i 99Etli = TOTR llUMBER OF BATCM MLEASE1.

2. 2 O MitS = TOTAL TIMEIMIN.I FOR SAICM RELEASES.

3.1.56E194 = MIIMUM IIMEIMIN.I FOR A BATCM MLEASE.

4. 2.5fEtt3 = ArtHEE TIMIMIN.I FOR A BATCM MLEASE.

3.1.2M691 = NINIMull T! KININ.I FOR A BATCH MLEASE.

f t. 49pORML MLEAMS A. LIOUIB 0.0

1. MUM 9ER OF MLEASE5

2. TOTAL ACTIv!TT MLEE(Hfililli~,,,,,,,0,0 I. CASEOUS l

1. NUMER OF MtEASE1 0.0

2. TOIR ACTITIIT MLEASEllCURIEll-0.0 t

8509190547 850630 DR ADOCK 05000413 PDR t

b k

N I

CA14u04 NUCLEAR SIAIION RG10ACilVE EFFLUENT BELEASE5 Bali. C0/27105 I LIGUID RELE45E5 YEAR. 1995 UNIll lli OTR 2NB Of8

$UITOTAL 1 G8055 Ret!DACTillTT 4.

TOTAL RELEASE CUGIES 7.01E-03 3.54E-01 3 ale-St 8.

AVERAGE CONCENTHI!ON RELEASES UCIINL 3 90E 10 1.49E-00 9 2&E-09 C.

NAIINUN CONCENTIAIION BELEA5Et UCIINL 1.14E-09 4.24E-40 4 26E-00 2 IRII!UN A.

10TAL RELEASE CUA!El 3.lM600 2.06E401 2.37E601 8.

AVERAGE CONCENTIATION RELEASES UCIf E 1.77E-07 9.01E-07 6.0M-0F 3.

01550 LMB NOBLE CASES A.

TOTAL RELEASE CURIES 7.7K-04 S 09E-03 6.47E-03 8.

AVERAGE CONCENI NTION M LEASED UCIfML 4.5M-It 2.IIE-10 1.71E-10 4.

CR055 ALPNA ACilflif A.

TOT E MLE45E CURIE 5

0. 0M100 0.0MlH 0.0M600 8.

AMRAGE CONCENTRAi!0N MLEASED UCIlE 0.0MlH

0. 0M F00 0.0Mt00 5.

VolulE OF LIGUIS un5fE TO 315CHAIGE CANAL LITE 85 1.03EtH 2.4MlH 4.3MlH 4.

90 LUNE OF BILUTION MATER LITERS 1.0 Mile 2.1 Mile 3.09Efl0 7.

Rat!0NUCLI M 5 MLEASES CURIE 5 NA-24 6.41E-04 6.4fE-03 7.34E-03 Ca-St 5.30E-04 S.2M-02 5.20E-02 NN-54

1. 0M-84 4.16E-03 4.26E-03 FE-55 0.00E600 1.NE-02 1.0E-02 FE-39

9. 5K-H 6.llE-03 4.02E-03 CD-57 0.00E600 6.14E-04 6.14E-04 CD-SS 3.70E-03 2.30E-01 2.4M-01 CD-60 9.61E-05 5.2M-03 S.34E-03 IN-65 0 IMitt

4. 0M-05 6.0M-05 5E-75

0. 0M100 4.9M-84

4. tM-8 4 5E-99 0.00Et00 4.05E-05 4.05E-05 ZR-93 1.17E-05 2.00E-03 2.0!E-03 NO-95 0.00Et00 2.1M-03 2.1M-03 MS-tf

1. f M-05 2.21E-05 4.14E-05 NO-99 0.0H 600 1.92E-04 1.92E-04 TC-9?N 1 29E-04 S.09E-04 7.10E-04 AG-100N 0.00Et00 2.64E-05 2.64E-05 AC-110N 0.00E100 1.3M-05 1.50E-05 50-122 1.3fE-05 3.10E-04 3.24E-04 50-124 0.00E100 7.3SE-03 7.35E-03 50-125 0.00Et00 1.04E-03 1.06E-03 I-131 4.14E-04 2.56E-03 3.01E-03 I-133 4 67E-04 4.37E-03 4.0E-03 I-134 0.00El00 3.16E-06 3.16E-06 I-135 0 00Et00 0 40E-04 0.40E-04 C5-137 0.00E100 1.05E-04 1.05E-04 04-140 0.00E400 2.00E-04 2.00E-04 LA-140 6.41E-03 2.52E-03 2.StE-03 CE-141

0. 0Kf 00 54M-H 5.4M-84 CE-144 0.0M100 2.2M-05 2.20E-05 U-107 7.50E-04 2.5M-03 3.31E-03 NP-239 3 OM-86 1 54E-03 1.34E-03 BR-05N 0.00El00 S.0?E-04 5.09E-04 IE-133N 0.00El00 4.lM-05 4.lM-0S XE-133 4 6tE-04 3.ITE-03

4. 24E-03 IE-135 3.0iE-04 2.07E-03 2.30E-03 i

to T0u utsN TO P0lNT TN!5 MPoni Of uutit artN I

CATAWBA LIQUID DOSE-SEMI-ANNUAL '85 NRC SUBMITTAL-IST STR-8/27/85 00000010 i

SKIN MAXIMUM DOSE-1.03D-04 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-SHORE Ch 58 38.55 %

CO 60 56.88 %

BONE MAXIMUM DOSE-1.26D-04 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-SHORE NA 4

9.01 X CO 4

27.10 %

CO O

39.81 %

I 131 7.07 %

M 187 11.91 X LIVER MAXIMUM DOSE-3.57D-04 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH H

3

.44 %

i MN 54

.82 %

i CO 58 2.96 %

CO 60 14.89 %

T. BODY MAXIMUM DOSE-3.54D-04 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH H

3 36.91 %

CO 58 36.12 %

CO 60 16.09 %

TNYROID MAXIMUM DOSE-4.63D-03 MREM CRITICAL AGE-CHILD CRITICAL PATHWAY-FISH I 131 04.85 %

I 133 10.64 X KIDNEY MAXIMUM DOSE-2.71D-04 MREM CRITICAL AGE-TEEN CRITICAL PATHNAY-FISH H

3 48.17 %

MN 54 7.07 %

CD SS 12.55 %

CO 60 18.44 X 1 131 7.79 %

i LUNG MAXIMUM DOSE-2.31D-04 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-SHORE H

3 6.58 %

CO 58 4.74 %

i CO 60 1.66 %

GI-LLI MA%IMUM DOSE-5.11D-03 MREM CRITICAL AGE-ABULT CRITICAL PATHNAY-FISH l

CO 58 16.40 %

l N 187 74.04 %

i 1

CATANSA LIqu!D DOSE-SEMI-ANNUAL '85 NRC SUBMITTAL-2HD QTR-8/27/45 00000010 SKIN MAXIMUM DOSE-5.44D-03 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-SHORE CD 58 40.85 %

CO 60 51.19 %

BONE MAXIMUM DOSE-1.47D-02 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH FE 55 5.34 %

CO 58

,2.87 %

CD 60

,6.06 %

CS 137 35.06 %

LIVER MAXIMUM DOSE-2.34D-02 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH MN 54 8.71 %

FE 59 97 %

CO SS l:ffX CO 60 CS 137 46.21 X T. BODY MAXIMUM DOSE-1.62D-02 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH CO 58 43.94 %

CO 60 16,63 %

CS 137 23.33 %

THYROID MAXIMUM DOSE-2.58D-02 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH CO 58 7.35 %

CO 60 9.17 %

i 111 11:22 ;

KIDNEY MAXIMUM DCSE-1.02D-02 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH

~

M 3

7.19 %

MN 54 6.78 %

CO 58 18.60 X CD 60 21.21 %

CS 137

3. 24 %

LUHG MAXIMUM DOSE-7.77D-03 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-SHORE N

3 9.44 %

FE 59 6.91 %

CD 58 24.42 %

CD 60 30.46 %

CS 137 14.80 %

GI-LLI MAXIMUM DOSE-4.14D-01 MREM CRITICAL AGE-ADULT CRITICAL PATHWAY-FISH CO 58 11.28 %

W %

8t.3a. L

CATAWBA LIQUID DOSE-SEMI-ANMUAL '85 NRC SUBMITTAL-TOTAL-8/27/85 00000010 SKIN MAXIMUM DOS.E-5.94D-03 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-SHORE CD 58 40.87 %

CO 60 51.23 X BONE MAXIMUM DOSE-1.60D-02 MREM CRITICAL AGE-1EEN CRITICAL PATHWAY-FISH FE 55 5.30 %

CO 58 12.99 %

CO 60 16.21 %

CS 137 S4.66 %

LIVER MAXIMUM DOSE-2.54D-02 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH a

MN 54 8.80 X FE 59 6.89 %

CO SS 17. 9 :, %

CO 60 10.8;, X%

CS 137 45.6;,

T. BODY MAXIMUM DOSE-1.78D-02 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH H

3 5.10 %

CO 58 43.44 %

CO 60 16.59 %

CS 137 22.89 %

THYROID MAXIMUM DOSE-3.16D-82 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH CD 58 6.57 %

CO 60 8.20 %

I 111 II:lii KIDNEY MAXIMUM DOSE-1.12D-02 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-FISH H

5 8.09 %

MN 54 6.79 %

CO 58 18.49 %

CD 60 23.08 %

CS 137 35.43 %

LUNG MAXIMUM DOSE-8.56D-03 MREM CRITICAL AGE-TEEN CRITICAL PATHWAY-SHORE N

3 10.59 %

FE 59 6.75 %

Co 58 24.21 %

CO 60 30.22 %

CS 137 14.34 %

GI-LLI MAXIMUM DOSE-4.49D-01 MREM CRITICAL AGE-ADULT CRITICAL PATHWAY-FISH ca 58 It.3% &

)

wb M go.%5%

I i

CAIAWed NUCtE 3 STAllC9 t'.fl0 ACTIVE EFFLUENT RELEASE 5 BATE. GCittitS II. AIM 0HE ELEASE5 YEM : ties UNIT 5 15T til 24 lit Sutf0ft 1.

10f t NOBLE CASES Cut!El 1.SSEtel 3.35EHI 4.90E601 2 TOTE HALOGEN 5 Cut!El 4.tMilt 1.tN-49 1.22E-09 3.

TOTE PMi!CULATE E0055 M TA-GANNA CUBIES 4.0M t04 0.4M6H 6.0M194 4.

TOTE TRIT!un CUBIES 0.9N-43 1.3M-41 1.5M-01 TOTE PMIICULATE G8055 R PNA ACTit!TT CUBIE5 0.9Mt44 0.00EtM t tMite 6.

MI! NUB NIOLE CA5 BELEAM BAIE UCIllEC 1.6Mies 1.6 Mitt 1.6tEt03 7.

HOIONUCLitEl MLEAWB CUBJE5 PMI!CULATE5 I

MALOGENS I-131 0.4M640 0.01E-10 0.StE-10 1-133 4.tMitt

4. tM-It 4.1&E-te e

GAMS El-SSN 2.09E-et 2.1M-48

f. Sit-et it-OS

1. TM-t!

9.4MtM

1. 7M-tt 58-87 7 SM-St 9.4MtM

7. 9N-68 It-te S. lM-01 F.NE-43 8.tM-tt IE-133N 4.00ElH 1.30E-et 1.IIE-81 IE 133 0.46Et04 3.IIEH1 4.06Elet IE-135 1.tM640 3.3M-41 1.79Ette M-41 4.99EtH 6.3fE-01 S.6MIM i

i h

i f

00 YOU WI5H Te Pe!NT TNIS M P90T 07 UNITT 17181 l

t l

i 2

4 l

1 i

1 r

i l

f

l CATAWBA GAS RELEASES-SEMI-ANNUAL '85 NRC SUBMITTAL-1ST QTR-8/21/85 00000020 BISPERSION FACTOR-3.10E-OS SEC/CU-M DEPOSITION FACTOR-7.30E-10 M(-2)

BETA AIR DOSE-3.02E-02 MILLIRADS GAMMA AIR DOSE-5.63E-02 MILLIRADS T. BODY CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-3.73D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 48 8.58%

AR 41 81.43%

GI-TRACT CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-3.73D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 88 4.SSX AR 41 81.43%

BONE CRITICAL AGE-INFANT CRITICAL PATHWAY-PLUME MAXIMUM DOSE-3.73D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 88 81 58%

8 l

AR 41 43%

4 LIVER CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAX! MUM DOSE-3.73D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 48 4.SSX AR 41 81.43%

KIDNEY CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-3.73D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 48 8.S8%

AR 41 81.43%

THYROID CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-3.73D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 48 8.S8X AR 41 81.43%

LUNG CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-3.74D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 48 8.57%

AR 41 81.12%

SKIN CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-6.37D-02 MILLIREM PLUME CONTRIBUTION-100.007; KR 48 6.91%

XE133 7.57%

XE135 6.46%

AR 41 76.34%

THYROID AGE-ADULT CRITICAL PATHWAY-PLUME TOTAL DOSE-3.73D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 88 8.SS%

AR 41 81.43%

THYROID AGE-INFANT CRITICAL PATHWAY-PLUME TOTAL DOSE-3.73D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 88 8.58%

AR 41 81.43%

i l

i

\\

I 4

L A

L L

7' 5

5 7

7 0

7 7

5 5

0 5

5 5

8 3

9 9

0 9

9 9

9 5

8 8

0 8

8 8

8 9

1 N

N N

N N

N N

N O

O O

O O

O O

O I

I I

I I

I I

I T

T T

T T

T T

T 6

4

~

U U

U U

U U

U U

1 0

B B

B B

B B

B B

I I

I I

I I

I I

3 3

R R

R R

R R

R R

9 9

T T

T T

T T

T T

N N

N N

N N

N N

O O

O O

O O

O O

C C

C C

C C

C C

N N

O O

E E

E E

E E

E E

I I

M M

M M

M M

M M

T T

U U

U U

U U

U U

U U

L L

L L

L L

L L

B B

P P

P P

P P

P P

I I

R R

T T

M M

M M

M M

M M

N N

E E

E E

E E

E E

O O

R R

R R

R R

R R

C C

I I

I I

I I

I I

L L

L L

L L

L L

E E

L L

L L

L L

L L

M M

I I

I I

I I

I I

U U

M M

M M

M M

M M

L L

P P

2 2

2 2

2 2

2 2

0 0

8 8

0 0

0 0

M M

D D

D D

D D

D D

E E

5 5

2 5

5 4

0 0

R A

2 2

1 2

2 2

2 8

I I

L L

0 1

1 1

1 1

1 1

2 L

L 2

I I

0 M

M 0

)

0 2

E E

E E

E E

E E

2 2

0

- S S

S S

S S

S S

S 0

0 0

(

D O

O O

O O

O O

O 0

M A D

D D

D D

D D

D D

D R

0 0

5 0 I M

M M

M M

M M

M 2

2 8

1 L U

U U

U U

U U

U

/

- L M

M M

M M

M M

M 1

1 1

E I I

I I

I I

I I

I 2

0 M X

X X

X X

X X

X

/

3 A

A A

A A

A A

A 2

M M

M M

M M

M M

E E

8 7 0 S

S O

O R

E D

D T

- 2 L

L Q

R 8 O

E E

E

. E E

E E

E A

A D

T 1 M

M M

M M

M M

M T

T N

C U

U U

U U

U U

U O

O 2

A L

L L

L L

L L

L T

T F -

P P

P P

P P

P P

E L

N S A

O O Y

Y Y

Y Y

Y Y

Y T

I D A

A A

A A

A A

A T

T W

W W

W W

W W

W E

E I

I R H

H H

H H

H H

H M

M M

S I T

T T

T T

T T

T U

U B

O A A

A A

A A

A A

A L

L U

P P

P P

P P

P P

P P

P S

E A D M L

L L

L L

L L

L C

M A

A A

A A

A A

A Y

Y R

A C

C C

C C

C C

C A

A N

G I

I I

I I

I I

I W

W T

T T

T T

T T

T H

H 5

I I

I I

I I

I I

T T

8 M

R R

R R

R R

R R

A A

C C

C C

C C

C C

P P

U L

C S L

L A

/ D T

A A

U C A D

D N

D D

D D

D C

C N

E R L

L A

L L

L L

L I

I N

S I I

I F

I I

I I

I T

T A

L H

H N

H H

H H

H I

I 5 L C

C I

C C

C C

C R

R I

0 I C

C M

- M E

E S

0 2 T

0 E

E E

E E

E E

E T

N 1

G G

G G

G G

G G

L A

S 3 E A

A A

A A

A A

A U

F E

8 D

N L

L L

L L

L L

L A

I S

6 A

A A

A A

A A

A A

E R 3 C

C C

C C

C C

C L

O I%%%% I%%%% I%%% I%%%% I%%%% I%%%% I%%%% I%%%

%%%g 656 E

T T3350 T3350 T073 T3350 T3350 T3350 T5006 T800 4265 C.15. h.

E9 I4 I297 I4 I41 I4131 I1332 I432 E8 R.131 R. 31 G.253 R

C -

I4131 R

R..*

R R.

R A E R

• A645K S

F S C0251 C0251 C454 C0 C0251 C0251 C0350 C562 A6452 5

A O

15 3 15 3 5 3 1S 3 15 3 15 3 15 3 6 2 5 3 G

N D O

I R T

D D

D U3351 B

S I Y

C I3351 G3351 N351 I3351 I335 W

R A D3351 A3351 E351 R3351 33 M A

E O 334 R 334 N334 E 334 N 334 O 334 N 334 I334 O 334 O 11 T 11 O11 V 11 D 11 R 11 U 11 K11 R 11 R

11 T

P A B. EER - EER BEER I EER I EER Y EER L EER S2ER Y EER Y EE f A

S T C

I E THXXA IHXXA XXA LNXXA KMXXA HNXXA MVXA XXA HHXXA HMXX$

D B G

T T

T l1' l

l

~

o CATAWBA GAS RELEASES-SEMI-ANNUAL '85 NRC SUBMITTAL-TOTAL-8/21/85 00000020 DISPERSION FACTOR-3.10E-05 SEC/CU-M DEPOSITION FACTOR-7.30E-10 M(-2)

BETA AIR DOSE-6.70E-02 MILLIRADS GAMMA AIR DOSE-7.44E-02 MILLIRADS T. BODY CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-4.97D-02 MILLIREM PLUME CONTRIBUTION-97.39%

KR 88 6.57%

XE133 16.53%

AR 41 68.78%

GI-TRACT CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-4.97D-02 MILLIREM PLUME CONTRIBUTION-97.39%

KR 88 6.57%

XE133 16.53%

AR 41 68.78%

BONE CRITICAL AGE-INFANT CRITICAL PATHWAY-PLUME MAXIMUM DOSE-4.84D-02 MILLIREM PLUME CONTRIBUTION-100.00%

KR 88 6.75%

XE133 6.97%

AR 41 0.63%

LIVER CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-4.97D-02 MILLIREM PLUME CONTRIBUTION-97.39%

KR 88 6.57%

XE133 16.33%

AR 41 68.78%

KIDNEY CRITICAL AGE-CHILD CRITICAL PATHMAY-PLUME MAXIMUM DOSE-4.97D-02 MILLIREM PLUME CONTRIBUTION-97.39%

KR 88 6.57%

XE133 16.53%

AR 41 68.78%

THYROID CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-4.97D-02 MILLIREM PLUME CONTRIBUTION-97.39%

KR 88 6.57%

XE133 16.53%

AR 41 68.78%

LUNG CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-5.02D-02 MILLIREM PLUME CONTRIBUTION-97.41%

KR 88 6.53%

XE133 17.20%

AR 41 68.11%

SKIN CRITICAL AGE-CHILD CRITICAL PATHWAY-PLUME MAXIMUM DOSE-9.16D-02 MILLIREM PLUME CONTRIf,UTION-98.58%

XE133 25.27%

XE135 6.44%

AR 41 59.77%

THYROID AGE-ADULT CRITICAL PATHWAY-PLUME TOTAL DOSE-4.92D-02 MILLIREN PLUME CONTRIBUTION-98.34%

KR 88 6.64%

XE133 16.69%

AR 41 69.45%

THYRCIP AGE-INFANT CRITICAL PATHWAY-PLUME TOTAL DOSE-4.92D-02 MILLIREM PLUME CONTRIBUTION-98.30%

KR 88 6.64%

XE133 16.68%

AR 91 69.43%

m-u i

t CATAWBA NUCLEAR STATION l

The estimated percentage of error for both Liquid and Gaseous effluent release data at Catawba Nuclear Station has been-l determined to be +234.

This number was derived by summing the following individual estimates of errors:

1) Flow rate determining devices = + 51

]

2) Counting error

= +154

3) Sample preparation error

= + 34 e

t i

i i

I c

I o

JMS/pja.002 l

I

..-... --.n.

f f

DUKE Pownn Gom%NY P.O. HOX 33180 CILAHLOTTE N.C. 282-42 ILE B. TUCKER rnernome WWE PARSEDS15v (70 6) 373-nsts August 29, 1985 m...--m Dr. J. Nelson Grace, Regional Administrator 3

U. S. Nuclear Regulatory Commission Region II 101 Marietta Street, NW, Suite 2900 Atlanta, Georgia 30323 q

E

Subject:

Catawba Nuclear Station Docket Nos. 50-413 and 50-414 y

Semi Annual Radioactive Ef fluent Release Report c3 N

Dear Sir:

Pursuant to Catawba Nuclear Station's Technical Specification 6.9.1.7, attached is the Semi Annual Radioactive Effluent Release Report for covering the period for initial criticality on January 7, 1985 through June 30, 1985. This report contains data for liquid and gaseous releases. No solid waste was released during this time period.

Very truly yours, b-f$

Hal B. Tucker WLH: sib Attachment cc:

Mr. Harold R. Denton, Director Palmetto Alliance Office of Nuclear Reactor Regulation 2135b Devine Street U. S. Nuclear Regulatory Commission Columbia, South Carolina 29205 Washington, D. C.

20555 Robert Guild, Esq.

P. O. Box 12097 Charleston, South Carolina 29412 NRC Resident Inspector Catawba Nuclear Station Mr. Jesse L. Riley Carolina Environmental Study Group 854 Henley Place Charlotte, North Carolina 28207 DESIgATEDORIGINAL /

Certified ay1(tt(i/ / 'dik 75 -100 Sc~O d>6 to raeusat. Been(

IFM

'l 1

--